GENG Ya, XU Hai-yu, MA Yue-xiang, et al. Composition Principles of Formula Containing Shengmaisan in [J]. Chinese journal of experimental traditional medical formulae, 2017, 23(1): 200-205.
DOI:
GENG Ya, XU Hai-yu, MA Yue-xiang, et al. Composition Principles of Formula Containing Shengmaisan in [J]. Chinese journal of experimental traditional medical formulae, 2017, 23(1): 200-205. DOI: 10.13422/j.cnki.syfjx.2017010200.
Composition Principles of Formula Containing Shengmaisan in
Objective: To apply TCMISS (V2.5) to analyze the composition principles of formula containing Shengmaisan in Dictionary of Chinese Medicine Prescription (Ginseng Radix et Rhizoma
Ophiopogonis Radix
Schisandrae Chinensis Fructus) and provide a basis for clinical medication and new drug research and development. Method: Formulas containing Ginseng Radix et Rhizoma
Ophiopogonis Radix and Schisandrae Chinensis Fructus in Dictionary of Chinese Medicine Prescription were collected
sorted and entered TCMISS to build a database and analyze their medication rules and major indications. Result: The database records a total of 415 formulas
25 core drug compositions and 25 TCM compatible with Shengmaisan and selects blood drug ‘Angelicae Sinensis Radix’
Qi drug ‘Astragali Radix’
Yin drug ‘Cornt Fructus’ and Yang drug ‘Aconiti Lateralis Radix Praeparaia’ to analyze drug compositions. It is suggested that although changes in formulas containing Shengmaisan are complex
generally they still give priority to tonifying Qi and Yin. As compatibility changes
the characteristics of treatment differ. Conclusion: Dictionary of Chinese Medicine Prescription has a wide range of compatible drugs for Shengmaisan. The characteristics of treatment are clear. Most of them are tonic and beneficiary. Composition principles reflect the composition features of Shengmaisan when treating different diseases. They have a guiding significance for modern clinical application and provide a basis for modern inheritance and development of formulas containing Shengmai San.
Mechanism of Shengmaisan in Regulating Mitochondrial Function in Cardiotoxic Rats
Clinical Observation of Shengmaisan Combined with Polymyxin B in Treatment of Sepsis Complicated with Severe Acute Respiratory Distress Syndrome
Mechanism of Shengmaisan Regulating Cardiac Remodeling of Arrhythmias with Deficiency of Qi and Yin
Evaluation of Clinical Efficacy of Shengmaisan Granules in Inhibiting Myocardial Fibrosis in Patients with Chronic Heart Failure with Qi-Yin Deficiency Syndrome Based on CMR
Mechanism of Shengmaisan in Atrial Fibrillation Based on Network Pharmacology
Related Author
TIAN Qingqing
KANG Lanfang
LI Xia
TIAN Hongli
GUO Wenjuan
LIU Jiao
CHENG Jie
ZHANG Yu
Related Institution
Hebei Industrial Technology Institute for Traditional Chinese Medicine Preparation
Hebei Provincial Hospital of Chinese Medicine
Hebei University of Chinese Medicine
Health Supervision Institute of Huaiyin District
Shandong University of Chinese Medicine Affiliated Hospital